# Jon Fairest

> Jon Fairest is a Series B investor at Sanofi (Croissy-sur-seine) backing Retail and Women's. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Sanofi](https://shizune.co/investors/profile/sanofi)
- Location: Croissy-sur-seine, France
- Total investments: 2
- Last investment: Sep 2024
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/jon-fairest-30133422/

Jon Fairest is a Series B investor at Sanofi in Croissy-sur-seine focused on Retail and Women's. Jon Fairest is the Global Head of Trade and Revenue at Sanofi.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Retail | 1 | 50% |
| Women's | 1 | 50% |
| mHealth | 1 | 50% |
| Big Data | 1 | 50% |
| Wellness | 1 | 50% |

10 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 1 | 50% |
| Venture - Series Unknown | 1 | 50% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Kenya | 1 | 50% |
| Singapore | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Kasha | Kasha is an innovative e-commerce platform based in East Africa, built for women's health, personal care, and beauty products accessibility within urban and rural areas. Kasha offers a comprehensive integrated basket of products that promotes health at all stages of life, including newborn child health, maternal health, menstrual hygiene,family planning, sexual and reproductive health, non-communicable diseases (e.g., hypertension and diabetes), and HIV/AIDS prevention and treatment. |  | Venture - Series Unknown | Sep 02, 2024 |  |
| SwipeRx | mClinica develops mobile platforms that strengthen the pharmaceutical supply chain, generate data, improve patient adherence to medication, and build the capacity of the pharmacy workforce. Since 2017, mClinica has connected 150,000 pharmacy professionals and 40,000 pharmacies through a single digital channel. Their users reach approximately 150million patients each month. mClinica currently operates across Indonesia, Philippines, Vietnam, Cambodia, Thailand, Malaysia, and Singapore with capacity for expansion. Their team is composed of over 120 team members including experts in public health, data science, and pharmacy. mClinica is supported by impact investors like the Global Innovation Fund (backed by USAID, UKAID, DFAT, Swedish Government, and the Omidyar Network) and Patamar Capital (formerly Unitus Impact) as well as other investors from the US, Europe, and Asia. mClinica implements projects both digitally and on the ground to connect the world’s pharmacies and transform global health. mClinica follows a social enterprise business model in which they seek double-bottom line returns – maximizing both financial returns and social impact.mClinica’s rapid growth and success is increasingly recognized. mClinica was the recipient of the Data Driven Apps Award of the World Government Summit in 2019, USAID-FHI360 Data for Resilience Award, Pierre Fabre Foundation Prize for eHealth Innovation, and Hack Osaka. The company has consistently been recognized as one of the most innovative startups in healthcare in Asia Pacific. | $10M | Series B | Feb 09, 2023 |  |

2 of 2 investments shown.

## Co-investors
- [Cercano Management](https://shizune.co/investors/profile/cercano-management) — VC Fund, 1 deal together
- [Johnson & Johnson Services, Inc.](https://shizune.co/investors/profile/johnson-johnson) — VC Fund, 1 deal together
- [Patamar Capital](https://shizune.co/investors/profile/patamar-capital) — VC Fund, 1 deal together
- [Susquehanna International Group](https://shizune.co/investors/profile/susquehanna-international-group-llp) — VC Fund, 1 deal together

## About Sanofi

VC Fund · Paris, France

Sanofi offers research, development, manufacturing, and marketing of innovative therapeutic solutions. It covers areas such as diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health, and the new G enzyme.

5 contacts available at Sanofi.

| Name | Title | Profile |
| --- | --- | --- |
| Jon Fairest | Global Head of Trade and Revenue | https://shizune.co/investors/profile/jon-fairest |
| William Napoli | Principal Engineer | https://shizune.co/investors/profile/william-napoli |
| Christophe Hirtz | Source to Pay project Lead | https://shizune.co/investors/profile/christophe-hirtz |
| Frank Nestle | Global Head of Research and Chief Scientific Officer | https://shizune.co/investors/profile/frank-nestle-4bd1 |
| Franqui Jimenez | Business Partner Rare Disease Cluster, Global MSAT | https://shizune.co/investors/profile/franqui-jimenez |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Jon Fairest invest in?

Jon Fairest invests primarily in Retail, Women's and mHealth startups, most often at Series B and Venture - Series Unknown stage. Most of the 2 investments tracked by Shizune back companies in Kenya. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Jon Fairest last invest?

The most recent investment recorded for Jon Fairest closed in Sep 2024. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co